{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:39:36Z","timestamp":1791088776548,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T00:00:00Z","timestamp":1214438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00213-008-1235-3","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T14:49:59Z","timestamp":1214405399000},"page":"521-527","source":"Crossref","is-referenced-by-count":113,"title":["Predicting response to opiate antagonists and placebo in the treatment of pathological gambling"],"prefix":"10.1007","volume":"200","author":[{"given":"Jon E.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suck Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,26]]},"reference":[{"issue":"11","key":"1235_CR1","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","volume":"156","author":"RF Anton","year":"1999","unstructured":"Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156(11):1758\u20131764","journal-title":"Am J Psychiatry"},{"issue":"17","key":"1235_CR2","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton RF, O\u2019Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A, COMBINE Study Research Group (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295(17):2003\u20132017","journal-title":"JAMA"},{"issue":"3","key":"1235_CR3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/scnp.2001.22921","volume":"6","author":"C Blanco","year":"2001","unstructured":"Blanco C, Moreyra P, Nunes EV, S\u00e1iz-Ruiz J, Ib\u00e1\u00f1ez A (2001) Pathological gambling: addiction or compulsion? Sem Clin Neuropsychiatry 6(3):167\u2013176","journal-title":"Sem Clin Neuropsychiatry"},{"issue":"1","key":"1235_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2007.06.043","volume":"75","author":"JA Brewer","year":"2008","unstructured":"Brewer JA, Potenza MN (2008) The neurobiology and genetics of impulse control disorders: Relationships to drug addictions. Biochem Pharmacol 75(1):63\u201375 [Epub 2007 Jul 3 ahead of print]","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1235_CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0091-3057(79)90137-0","volume":"11","author":"CL Broekkamp","year":"1979","unstructured":"Broekkamp CL, Phillips AG (1979) Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area. Pharmacol Biochem Behav 11(3):289\u2013295","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"1235_CR6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1176\/appi.ajp.160.6.1041","volume":"160","author":"RA Chambers","year":"2003","unstructured":"Chambers RA, Taylor JR, Potenza MN (2003) Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 160(6):1041\u20131052","journal-title":"Am J Psychiatry"},{"key":"1235_CR7","first-page":"415","volume":"70","author":"R Fuente-Fern\u00e1ndez de la","year":"2006","unstructured":"de la Fuente-Fern\u00e1ndez R, Lidstone S, Stoessl AJ (2006) Placebo effect and dopamine release. J Neural Transm Suppl 70:415\u2013418","journal-title":"J Neural Transm Suppl"},{"issue":"8","key":"1235_CR8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00406-006-0668-0","volume":"256","author":"B Dell\u2019Osso","year":"2006","unstructured":"Dell\u2019Osso B, Altamura AC, Allen A, Marazziti D, Hollander E (2006) Epidemiologic and clinical updates on impulse control disorders: a critical review. Eur Arch Psychiatry Clin Neurosci 256(8):464\u2013475","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1235_CR9","volume-title":"Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I\/P, Version 2.0)","author":"MB First","year":"1995","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I\/P, Version 2.0). New York Biometrics Research Department, New York State Psychiatric Institute, New York"},{"key":"1235_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/med:psych\/9780195304145.003.0020","volume-title":"A guide to treatments that work, 3rd edition","author":"JE Grant","year":"2007","unstructured":"Grant JE, Potenza MN (2007) Treatments for pathological gambling and other impulse control disorders. In: Nathan PE, Gorman JM (eds) A guide to treatments that work, 3rd edition. Oxford University Press, New York, pp 561\u2013571"},{"issue":"2","key":"1235_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","volume":"163","author":"JE Grant","year":"2006","unstructured":"Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A (2006) A multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163(2):303\u2013312","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1235_CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v69n0511","volume":"69","author":"JE Grant","year":"2008","unstructured":"Grant JE, Kim SW, Hartman BK (2008) A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, for the treatment of pathological gambling urges. J Clin Psychiatry 69(5):783\u2013789","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1235_CR13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32(1):50\u201355","journal-title":"Br J Med Psychol"},{"key":"1235_CR14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"1235_CR15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","volume":"47","author":"E Hollander","year":"2000","unstructured":"Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C (2000) A randomized double-blind fluvoxamine\/placebo crossover trial in pathological gambling. Biol Psychiatry 47(9):813\u2013817","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1235_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","volume":"162","author":"E Hollander","year":"2005","unstructured":"Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N (2005) Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 162(1):137\u2013145","journal-title":"Am J Psychiatry"},{"issue":"11","key":"1235_CR17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","volume":"49","author":"SW Kim","year":"2001","unstructured":"Kim SW, Grant JE, Adson DE, Shin YC (2001) Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49(11):914\u2013921","journal-title":"Biol Psychiatry"},{"issue":"13","key":"1235_CR18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0024-3205(89)90589-4","volume":"44","author":"TR Kosten","year":"1989","unstructured":"Kosten TR, Kleber HD, Morgan C (1989) Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 44(13):887\u2013892","journal-title":"Life Sci"},{"issue":"6","key":"1235_CR19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.biopsych.2006.11.018","volume":"62","author":"S Krishnan-Sarin","year":"2007","unstructured":"Krishnan-Sarin S, Krystal JH, Shi J, Pittman B, O\u2019Malley SS (2007) Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol Psychiatry 62(6):694\u2013697","journal-title":"Biol Psychiatry"},{"issue":"24","key":"1235_CR20","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa011127","volume":"345","author":"JH Krystal","year":"2001","unstructured":"Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA, Veterans Affairs Naltrexone Cooperative Study 425 Group (2001) Naltrexone in the treatment of alcohol dependence.. N Engl J Med 345(24):1734\u20131739","journal-title":"N Engl J Med"},{"issue":"9","key":"1235_CR21","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1176\/ajp.144.9.1184","volume":"144","author":"HR Lesieur","year":"1987","unstructured":"Lesieur HR, Blume SB (1987) The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 144(9):1184\u20131188","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1235_CR22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1973.01750360022003","volume":"28","author":"WR Martin","year":"1973","unstructured":"Martin WR, Jasinski DR, Mansky PA (1973) Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.. Arch Gen Psychiatry 28(6):784\u2013791","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"1235_CR23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archpsyc.56.8.719","volume":"56","author":"BJ Mason","year":"1999","unstructured":"Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB (1999) A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56(8):719\u2013724","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"1235_CR24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0306-4522(84)90048-4","volume":"11","author":"RT Matthews","year":"1984","unstructured":"Matthews RT, German DC (1984) Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11(3):617\u2013625","journal-title":"Neuroscience"},{"issue":"3","key":"1235_CR25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/105504901750532148","volume":"10","author":"J Monterosso","year":"2001","unstructured":"Monterosso J, Flannery BA, Pettinati HM, Oslin DW, Rukstalis M, O\u2019Brien CP, Volpicelli J (2001) Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict 10(3):258\u2013268","journal-title":"Am J Addict"},{"issue":"3","key":"1235_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0924-977X(98)00050-9","volume":"9","author":"SA Montgomery","year":"1999","unstructured":"Montgomery SA (1999) The failure of placebo-controlled studies. ECNP Consensus Meeting, September 13, 1997, Vienna, European College of Neuropsychopharmacology. Eur Neuropsychopharmacol 9(3):271\u2013276","journal-title":"Eur Neuropsychopharmacol"},{"key":"1235_CR27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1176\/appi.ajp.162.8.1423","volume":"162","author":"CP O\u2019Brien","year":"2005","unstructured":"O\u2019Brien CP (2005) Anti-craving (relapse prevention) medications: possible a new class of psychoactive medication. Am J Psychiatry 162:1423\u20131431","journal-title":"Am J Psychiatry"},{"issue":"8","key":"1235_CR28","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","volume":"28","author":"DW Oslin","year":"2003","unstructured":"Oslin DW, Berrettini W, Krnazler H, Pettinati H, Gelernter J, Volpicelli J, O\u2019Brien CP (2003) A functional polymorphism of the mu opioid receptor gene is associated with naltrexone response in alcohol dependent patients. Neuropsychopharmacol 28(8):1546\u20131552","journal-title":"Neuropsychopharmacol"},{"issue":"4","key":"1235_CR29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10899-005-5557-3","volume":"21","author":"S Pallanti","year":"2005","unstructured":"Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E (2005) Reliability and validity of the Pathological Gambling Modification of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud 21(4):431\u2013443","journal-title":"J Gambl Stud"},{"issue":"9","key":"1235_CR30","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.64.9.1069","volume":"64","author":"LA Ray","year":"2007","unstructured":"Ray LA, Hutchison KE (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64(9):1069\u20131077","journal-title":"Arch Gen Psychiatry"},{"key":"1235_CR31","volume-title":"Fundamentals of Biostatistics, 4th ed","author":"B Rosner","year":"1995","unstructured":"Rosner B (1995) Fundamentals of Biostatistics, 4th ed. Duxbury, Belmont"},{"issue":"2","key":"1235_CR32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.06.028","volume":"55","author":"DJ Scott","year":"2007","unstructured":"Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2007) Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55(2):325\u2013336","journal-title":"Neuron"},{"key":"1235_CR33","volume-title":"The anxiety disease","author":"DV Sheehan","year":"1983","unstructured":"Sheehan DV (1983) The anxiety disease. Scribner\u2019s, New York"},{"key":"1235_CR34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archpsyc.57.7.666","volume":"57","author":"WS Slutske","year":"2000","unstructured":"Slutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M (2000) Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 57:666\u2013673","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"1235_CR35","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, O\u2019Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49(11):876\u2013880","journal-title":"Arch Gen Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1235-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1235-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:57:55Z","timestamp":1684439875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1235-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,26]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1235-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,26]]}}}